BIOMAT Database Logo BIOMAT Database Logo

Expression of the high mobility group proteins HMGI(Y) correlates with malignant progression in Barrett's metaplasia. 2004

Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Department of Pathology, Section of Gastroenterology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas, USA.

Expression of the high mobility group proteins HMGI(Y) has been shown to be a marker of malignancy in thyroid and pancreatic lesions and to correlate significantly with malignant progression in the colon. The aim of this study was to determine whether HMGI(Y) expression is associated with malignant progression in Barrett's metaplasia (BM). Immunoperoxidase staining for HMGI(Y) was performed on sections of formalin-fixed paraffin-embedded endoscopic esophageal biopsies from 42 patients with BM. These consisted of 19 biopsies negative for dysplasia (ND), 16 with low-grade dysplasia (LGD)/indeterminate for dysplasia (IND), and 7 with high-grade dysplasia (HGD)/adenocarcinoma (CA). The percentage of positive cells was recorded, and nuclear HMGI(Y) immunoreactivity in >10% of the cells was considered positive. Statistical analysis was performed using Fisher's exact test. Positive HMGI(Y) staining was detected in 2 of 19 (11%) cases ND, 5 of 16 (30%) LGD/IND cases, and 7 of 7 (100%) HGD/CA cases. Biopsies with HGD/CA were significantly more likely to be positive for HMGI(Y) than biopsies ND (P < 0.0001) or with LGD/IND (P = 0.0046). We conclude that HMGI(Y) expression is significantly associated with malignant progression in BM. Additional studies are needed to determine whether BM biopsies that are ND or LGD/IND and positive for HMGI(Y) are more likely to progress to adenocarcinoma.

UI MeSH Term Description Entries
D008679 Metaplasia A condition in which there is a change of one adult cell type to another similar adult cell type.
D006609 High Mobility Group Proteins A family of low-molecular weight, non-histone proteins found in chromatin. HMG Proteins,Calf Thymus Chromatin Protein HMG,High Mobility Group Chromosomal Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D001471 Barrett Esophagus A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus. Barrett Syndrome,Esophagus, Barrett,Barrett Epithelium,Barrett Metaplasia,Barrett's Esophagus,Barrett's Syndrome,Barrett Metaplasias,Barretts Esophagus,Barretts Syndrome,Epithelium, Barrett,Esophagus, Barrett's,Metaplasia, Barrett,Metaplasias, Barrett
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.
April 1995, Oncogene,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.
April 1996, Cancer research,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Expression of High Mobility Group Protein Family [HMGI(Y) and HMGI-C] in Human Breast Cancer.
August 2001, Cancer research and treatment,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Expression of the high-mobility group protein HMGI(Y) in gestational trophoblastic diseases.
January 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma.
January 2007, Acta oto-laryngologica,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.
January 2001, International journal of cancer,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.
November 1999, The American journal of pathology,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
September 1998, Cancer research,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
The high mobility group protein, HMGI-C.
July 1998, The international journal of biochemistry & cell biology,
Xueyun Chen, and Juan Lechago, and Atilla Ertan, and Gulchin Ergun, and Ray Verm, and Margaret Bridges, and Craig Johnson, and Karen Woods, and Frank Meriano, and Minni Chirala, and Mamoun Younes
Calcium-dependent ADP-ribosylation of high-mobility-group I (HMGI) proteins.
August 1996, The Biochemical journal,
Copied contents to your clipboard!